NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
about
sameAs
Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2DResistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cellsComparative genomics of natural killer cell receptor gene clusters.Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease RisksNatural killer cell differentiation driven by Tyro3 receptor tyrosine kinasesProtein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector FunctionsUp on the tightrope: natural killer cell activation and inhibitionAn approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signalingHuman IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsRole of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligaseMatched sizes of activating and inhibitory receptor/ligand pairs are required for optimal signal integration by human natural killer cells.Ligand dimensions are important in controlling NK-cell responses.A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseCostimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skinNKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivoTransforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production.The C-type lectin OCILRP2 costimulates EL4 T cell activation via the DAP12-Raf-MAP kinase pathway.NK cells: immune cross-talk and therapeutic implications.Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity.Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activationAntitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancerActivation of natural killer cells: underlying molecular mechanisms revealed.Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretionMultiplicity and plasticity of natural killer cell signaling pathways.Interplay of natural killer cells and their receptors with the adaptive immune response.The role of SH3BP2 in the pathophysiology of cherubism.Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease.Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.DNA damage and tumor surveillance: one trigger for two pathways.Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicityA requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
P2860
Q24647598-00F49789-79A3-40BC-BF55-8225617CA7ECQ24654966-DB0DED98-049A-44F3-83F2-5C947EBC4FDCQ24816578-0604AEE3-981D-49C5-B558-5B43EBD2D02EQ28066573-5EE0E3AD-6602-4758-90DD-10F761E5411CQ28587024-E278DEA8-8E1B-4D71-A1B7-3B766F9A1D4FQ28703128-2A14538A-A5D2-42C4-A18D-F22CF9282CD8Q29619175-BE6DEBDE-D3FB-48C3-9D05-4E50A999D6D3Q30400692-2F3101C2-01BA-450F-9E66-B158A234FC4CQ30538416-29BE6739-3F18-4A5B-92C2-67E98AC2556BQ33522918-AAD1211C-482D-4C83-8D1A-4D67E88B3BA5Q33642419-3D3986E7-B92B-4106-9D33-D0C2566344B1Q33745662-A801592D-720F-4041-92E9-AB96001A1649Q33778625-D8BB7698-F97C-4E0E-8B0C-91D2AFD90D74Q34017595-885FF58C-6BC8-49B2-9A85-8EACD47B1B07Q34146619-7A698F5A-10B6-49A2-9146-BD4AA0EE3D56Q34307792-F438D3CD-C750-428D-82F9-A32AA05FFD94Q34402566-32D0D099-0575-4ED1-9B38-77761F49E208Q34508406-927F55E4-17FE-470E-806D-C6EF1B8B1A5DQ34548289-68650B67-A00B-4BBE-96FB-D1A463F42E04Q35084254-980DC0B3-9C89-49E6-AF46-BEEC168B27EDQ35213081-5836BCD6-5267-4382-A674-7F345DD205B2Q35438880-13C3F284-9BBF-414A-B393-74F089E97B52Q35591444-D66BE0E0-9C43-4DF2-A011-39A448D15E6EQ35678024-0F9F00AC-DD87-4C42-BCB4-D5E9501046BDQ35748643-FCEB2F06-5F7B-4450-BA14-B9FCD9E2303EQ35794137-9A11D5AD-3F13-40B2-86B2-C29DA74A849CQ35810320-D41E19A4-0797-4FE0-A3CF-97F09B535DDEQ35817271-ACEF092B-4EBA-4099-B995-54B4453E7B5BQ35828150-BBFE63F7-FB47-4789-A5F9-FDA23BD393C4Q35847820-E9F58CA7-C2C9-4093-85D5-446FDDA43639Q35848493-8DD0F6DA-1D57-4903-A677-85EAF2F21FAFQ35849513-EA7501EB-52B5-48F2-9629-D6AA3DB52FB4Q35904393-B6573088-F525-49B7-8DA3-FB8CAA62170DQ35987370-61FF65AB-56A3-46C8-87F3-F0EBA5A1928EQ36080707-17C34B18-4823-4476-A841-DE6300606BD5Q36246252-C92985C1-94A6-45E3-A85F-77D5BAC25534Q36278732-81B3535D-E52C-44E2-82B6-CFA163D0155AQ36364988-69A8694F-73A3-4E6D-ABDD-DC248DBAC311Q36399700-4F3225B2-2A50-4C3A-903E-31A2AA64C315Q36403580-972FB576-6F05-44F2-A315-47B4E135E7E3
P2860
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@ast
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@en
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@nl
type
label
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@ast
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@en
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@nl
prefLabel
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@ast
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@en
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@nl
P2093
P2860
P3181
P356
P1433
P1476
NKG2D-DAP10 triggers human NK ...... independent regulatory pathway
@en
P2093
Christopher J Dick
Daniel D Billadeau
Jadee L Upshaw
Paul J Leibson
Renee A Schoon
P2860
P2888
P304
P3181
P356
10.1038/NI929
P407
P577
2003-06-01T00:00:00Z
P5875
P6179
1005523628